GSK presents positive cancer drug data
30th Nov 2005, 18:16 GMT
GlaxoSmithKline said it expected to have four cancer drugs in late-stage clinical trials next year as it seeks to boost its relatively small oncology drug portfolio.
GSK presents positive cancer drug data related news:
- GSK in drive for new cancer drugs — Business
- Glaxo Bullish on Cancer Drugs — Red Herring
- Hycamtin® receives positive opinion in Europe for treatment of patients with relapsed small cell lung cancer — Medical News Today RSS/XML Feed
- Glaxo to put cancer drugs into final trials — Reuters: Business
- Cancer Drug No Fertility Treatment — Health News: CBSnews.com
- Callisto Anti-Cancer Drug Atiprimod Chosen for 2nd High-Profile Oral Presentation at American Society of Hematology Meeting — Laboratory News from StratCenter.com
- New breast cancer drug shows promise — The Cancer Blog
- Cancer Drug Green Light — RedOrbit News - Health
- Novartis Warns About Breast Cancer Drug Use — NYNewsday.com Health and Science headlines
- Can healthcare systems afford Herceptin for early breast cancer? — EurekAlert! - Cancer
Latest news from FT.com / Home UK:
- KKR takes false reports fears to watchdog
- UK financiers hit out over reporting reform
- KB Home chief resigns over options scandal
- Marshall Wace taps Euronext
- Metals worries pull FTSE lower
- Marshall Wace taps Euronext
- 12% business tax proposed for N Ireland
- Marshall Wace aims for €1.5bn listing
- Smaller investors voice ITV doubts
- Fresh challenge to planned ITV bid